GIVLAARI 189 mg/ml, solution for injection bottle, 1 ml
Active ingredients: Givosiran, Givosiran sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GIVLAARI 189 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 1 mL
- Marketing authorisation holder
- ALNYLAM NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 May 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68318874CIP73021631CIP133400930216316Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GIVOSIRAN SODIQUEsolution | — | SA |
| GIVOSIRANsolution | 189 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.